GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allegra Medical Technologies Ltd (ASX:AMT) » Definitions » Piotroski F-Score

Allegra Medical Technologies (ASX:AMT) Piotroski F-Score : 2 (As of May. 20, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Allegra Medical Technologies Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Allegra Medical Technologies has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Allegra Medical Technologies's Piotroski F-Score or its related term are showing as below:

ASX:AMT' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 3   Max: 7
Current: 2

During the past 13 years, the highest Piotroski F-Score of Allegra Medical Technologies was 7. The lowest was 1. And the median was 3.


Allegra Medical Technologies Piotroski F-Score Historical Data

The historical data trend for Allegra Medical Technologies's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allegra Medical Technologies Piotroski F-Score Chart

Allegra Medical Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 4.00 3.00 1.00 2.00

Allegra Medical Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.00 - 2.00 -

Competitive Comparison of Allegra Medical Technologies's Piotroski F-Score

For the Medical Devices subindustry, Allegra Medical Technologies's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allegra Medical Technologies's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allegra Medical Technologies's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Allegra Medical Technologies's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun23) TTM:Last Year (Jun22) TTM:
Net Income was A$-3.65 Mil.
Cash Flow from Operations was A$-0.78 Mil.
Revenue was A$0.00 Mil.
Gross Profit was A$-0.01 Mil.
Average Total Assets from the begining of this year (Jun22)
to the end of this year (Jun23) was (5.609 + 2.913) / 2 = A$4.261 Mil.
Total Assets at the begining of this year (Jun22) was A$5.61 Mil.
Long-Term Debt & Capital Lease Obligation was A$2.68 Mil.
Total Current Assets was A$2.20 Mil.
Total Current Liabilities was A$1.72 Mil.
Net Income was A$-2.54 Mil.

Revenue was A$2.85 Mil.
Gross Profit was A$1.20 Mil.
Average Total Assets from the begining of last year (Jun21)
to the end of last year (Jun22) was (6.339 + 5.609) / 2 = A$5.974 Mil.
Total Assets at the begining of last year (Jun21) was A$6.34 Mil.
Long-Term Debt & Capital Lease Obligation was A$1.87 Mil.
Total Current Assets was A$4.38 Mil.
Total Current Liabilities was A$1.58 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Allegra Medical Technologies's current Net Income (TTM) was -3.65. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Allegra Medical Technologies's current Cash Flow from Operations (TTM) was -0.78. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun22)
=-3.648/5.609
=-0.65038331

ROA (Last Year)=Net Income/Total Assets (Jun21)
=-2.535/6.339
=-0.39990535

Allegra Medical Technologies's return on assets of this year was -0.65038331. Allegra Medical Technologies's return on assets of last year was -0.39990535. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Allegra Medical Technologies's current Net Income (TTM) was -3.65. Allegra Medical Technologies's current Cash Flow from Operations (TTM) was -0.78. ==> -0.78 > -3.65 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun22 to Jun23
=2.678/4.261
=0.62849096

Gearing (Last Year: Jun22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun21 to Jun22
=1.869/5.974
=0.31285571

Allegra Medical Technologies's gearing of this year was 0.62849096. Allegra Medical Technologies's gearing of last year was 0.31285571. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun23)=Total Current Assets/Total Current Liabilities
=2.196/1.715
=1.28046647

Current Ratio (Last Year: Jun22)=Total Current Assets/Total Current Liabilities
=4.38/1.576
=2.77918782

Allegra Medical Technologies's current ratio of this year was 1.28046647. Allegra Medical Technologies's current ratio of last year was 2.77918782. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Allegra Medical Technologies's number of shares in issue this year was 104.459. Allegra Medical Technologies's number of shares in issue last year was 104.459. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=-0.014/0
=

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1.201/2.853
=0.42096039

Allegra Medical Technologies's gross margin of this year was . Allegra Medical Technologies's gross margin of last year was 0.42096039. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun22)
=0/5.609
=0

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun21)
=2.853/6.339
=0.45007099

Allegra Medical Technologies's asset turnover of this year was 0. Allegra Medical Technologies's asset turnover of last year was 0.45007099. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+1+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Allegra Medical Technologies has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Allegra Medical Technologies  (ASX:AMT) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Allegra Medical Technologies Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Allegra Medical Technologies's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Allegra Medical Technologies (ASX:AMT) Business Description

Traded in Other Exchanges
N/A
Address
18-20 Orion Road, Level 8, Lane Cove West, Sydney, NSW, AUS, 2066
Allegra Medical Technologies Ltd is engaged in the research, product development, and manufacturing of medical devices including prosthetic implant tools. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip stems and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems among others. It operates in two segments Orthopaedics Division, which derives the majority of its revenue sells and distributes its portfolio of medical device products. Innovation Division which invests resources into the development and commercialization of new products to take to market.